Learn More
Invitrogen™ LanthaScreen™ Tb-p4E-BP1 (pThr46) Antibody
A part of the PI3K/AKT Pathway, 4E-BP1 (EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1) is a cytosolic protein that is phosphorylated at Thr46 by mTORC1 upon stimulation of the pathway.
Brand: Invitrogen™ PV4755
Description
A part of the PI3K/AKT Pathway, 4E-BP1 (EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1) is a cytosolic protein that is phosphorylated at Thr46 by mTORC1 upon stimulation of the pathway.
For use in combination with the GFP-4E-BP1 physiological protein substrate (Cat. No. PV4759) to evaluate inhibitors in medium to high throughput screening applications. An optimized mTor assay buffer (PV4794) is also available.
Specifications
| Serine/threonine kinase | |
| 0.52mg/mL | |
| 150kDa | |
| RUO | |
| Primary | |
| Terbium-labeled p4E-BP1 (pThr46) antibody in HEPES buffered saline. Store at -20°C. |
|
| 340/490, 520 nm | |
| Dry Ice | |
| Hu | |
| LanthaScreen |
| Kinase Assay, Target and Lead Identification and Validation | |
| Tb (Terbium)/Lanthanide Chelates | |
| 25 μg | |
| Kinase Biology | |
| 1 Each | |
| Liquid | |
| Human | |
| End Point | |
| Ser/Thr Kinases |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
For Research Use Only. Not for use in diagnostic procedures.